Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Arrow International, headquartered in Reading, Pennsylvania, USA, develops, manufactures and markets disposable catheters and related products for critical and cardiac care. Arrow's critical care products are principally used for central venous access in the administration of fluids, drugs and blood products, as well as for patient monitoring, diagnosis and pain management. The company's cardiac assist products are used in the diagnosis and treatment of patients with heart and vascular disease and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty.

In fiscal 2004, Arrow's revenue increased by 14% to US$52.7 million. Sales of critical care products grew by 14% to US$369.8 million, representing 85% of total revenue, while sales of cardiac care products rose by 11% to US$63.3 million.

Arrow operates US manufacturing sites in Wyomissing, Pennsylvania; Mount Holly, New Jersey; and Everett, Massachusetts. In addition, its plant in Asheboro, North Carolina, is being expanded to accommodate increased production requirements, while one in Winston Salem, North Carolina, will be closed as Arrow consolidates its North Carolina manufacturing operations; and the site in San Antonio, Texas, acquired with NeoCare will be sold. Arrow is also transferring production to its lower-cost plants in Mexico and the Czech Republic.